News
NIH is issuing an Intramural Research Program (IRP) policy to promote access to IRP-supported inventions resulting in drugs, biologics, vaccines, or devices. As of June 1, 2025, organizations applying to NIH for certain commercial patent licenses will be required to submit Access Plans to NIH
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
The National Institute for Allergy and Infectious Diseases (NIAID) has been recognized by the FLC for their impact on the public through their technology transfer work. NIH was awarded six of the 33 awards across nine different technology transfer categories, in addition to a COVID-19 Response award
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
The Association of University Technology Managers (AUTM) Annual Meeting is a chance for technology transfer professionals to get together – virtually this year – and hear from world-class speakers in over 60 educational workshops and roundtable discussions. NIH’s own Bruce Goldstein and Karen Rogers
![blank new placeholder image](/themes/custom/ott/images/news-card-placeholder.png)
The Centers for Disease Control and Prevention (CDC) and the National Institute for Allergy and Infectious Diseases (NIAID) have been rewarded for their partnership from the 2021 Federal Laboratory Consortium (FLC) awards. NIH was awarded six of the 33 awards across nine different technology